Free shipping on all orders over $ 500

MHY1485

Cat. No. M9050
MHY1485 Structure
Size Price Availability Quantity
10mg USD 75 In stock
50mg USD 250 In stock
100mg USD 400 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
Biological Activity

MHY1485 induced mTOR activation and correspondingly showed a higher docking score than PP242, a well-known ATP-competitive mTOR inhibitor, in docking simulation. In conclusion, MHY1485 has an inhibitory effect on the autophagic process by inhibition of fusion between autophagosomes and lysosomes leading to the accumulation of LC3II protein and enlarged autophagosomes. MHY1485 also induces mTOR activity, providing a possibility for another regulatory mechanism of autophagy by the MHY compound. MHY1485 treatment increases ribosomal protein S6 kinase (S6K) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) phosphorylation, which are downstream targets of mTOR complex 1 (mTORC1), but decreases phosphorylation of Akt on mTOR complex 2 (mTORC2) target site serine 473.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 387.39
Formula C17H21N7O4
CAS Number 326914-06-1
Purity 99.33%
Solubility DMSO: ≥ 7 mg/mL (Need ultrasonic and warming)
Storage at -20°C
References

Promotion of ovarian follicle growth following mTOR activation: synergistic effects of AKT stimulators.
Cheng Y, et al. PLoS One. 2015 Feb 24;10(2):e0117769. PMID: 25710488.

Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion.
Choi YJ, et al. PLoS One. 2012;7(8):e43418. PMID: 22927967.

Related mTOR Products
LY303511 hydrochloride

LY303511 hydrochloride is a structural analogue of LY294002. LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors.

CZ415

CZ415 is a potent ATP-competitive mTOR inhibitor with very good cell permeability.

GNE-477

GNE-477 is a potent and efficacious dual PI3K (IC50=4 nM)/mTOR(Ki=21 nM) inhibitor.

Zotarolimus

Zotarolimus (ABT-578) is an analogue of rapamycin, and inhibits FKBP-12 binding with IC50 of 2.8 nM.

LY303511

LY303511 is a structural analogue of LY294002, which does not inhibit PI3K, increased homotypic GJIC.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: MHY1485 supplier, mTOR, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.